Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses

Strahlentherapie und Onkologie

Volumn 183, Issue 2, 2007, Pages 63-68

  Combs, Stephanie E ^a,b   Konkel, Stephan ^a,b   Thilmann, Christoph ^a,b   Debus, Jürgen ^a,b   Schulz Ertner, Daniela ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Intensity modulated radiotherapy (IMRT); Paranasal sinus carcinoma; Radiotherapy; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DOSIMETRY; FEMALE; HISTOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MELANOMA; NOSE CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; RADIATION DOSE; RADIATION INJURY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NASAL CAVITY; NASAL MUCOSA; PARANASAL SINUS NEOPLASMS; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33846942998     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1616-2     Document Type: Article

References (67)

1. Andersen LJ, Berthelsen A, Hansen HS. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol 1992;21:180-5.
2. Barton RT. Mucosal melanomas of the head and neck. Laryngoscope 1975;85:93-9.
3. Bhandare N, Monroe AT, Morris CG, et al. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 2005;62:1070-7.
4. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664-78.
5. Chiu NT, Weinstock MA. Melanoma of oronasal mucosa. Population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg 1996;122:985-8.
6. Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part I: basic concepts and first analyses. Br J Cancer 2003;89:232-8.
7. Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part IV: further concepts and methods in survival analysis. Br J Cancer 2003;89:781-6.
8. Combs SE, Thilmann C, Debus J, et al. Precision radiotherapy for hemangiopericytomas of the central nervous system. Cancer 2005;104:2457-65.
9. Debus J, Engenhart-Cabillic R, Knopp MV, et al. [Image-oriented planning of minimally invasive conformal irradiation of the head-neck area.] Radiologe 1996;36:732-6.
10. De Meerleer GO, Vermeersch H, van Eijkeren M, et al. Primary sinonasal mucosal melanoma: three different therapeutic approaches to inoperable local disease or recurrence and a review of the literature. Melanoma Res 1998;8:449-57.
11. Ellingwood KE, Million RR. Cancer of the nasal cavity and ethmoid/sphenoid sinuses. Cancer 1979;43:1517-26.
12. Ernst-Stecken A, Lambrecht U, Mueller R, et al. Dose escalation in large anterior skull-base tumors by means of IMRT. First experience with the Novalis® System. Strahlenther Onkol 2006;182:183-9.
13. Franquemont DW, Mills SE. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol 1991;96:689-97.
14. Freedman HM, DeSanto LW, Devine KD, et al. Malignant melanoma of the nasal cavity and paranasal sinuses. Arch Otolaryngol 1973;97:322-5.
15. Gershkevitsh E, Clark CH, Staffurth J, et al. Dose to bone marrow using IMRT techniques in prostate cancer patients. Strahlenther Onkol 2005;181:172-8.
16. Gilligan D, Slevin NJ. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 1991;64:1147-50.
17. Guzzo M, Grandi C, Licitra L, et al. Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan. Eur J Surg Oncol 1993;19:316-9.
18. Harwood AR, Cummings BJ. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys 1982;8:1121-6.
19. Hocht S, Bechrakis NE, Nausner M, et al. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol 2004;180:419-24.
20. Hocht S, Stark R, Seiler F, et al. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison. Strahlenther Onkol 2005;181:783-8.
21. Holdcraft J, Gallagher JC. Malignant melanomas of the nasal and paranasal sinus mucosa. Ann Otol Rhinol Laryngol 1969;78:5-20.
22. Holmstrom M, Lund VJ. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med 1991;48:9-11.
23. Hormia M, Vuori EE. Mucosal melanomas of the head and neck. J Laryngol Otol 1969;83:349-59.
24. Iversen K, Robins RE. Mucosal malignant melanomas. Am J Surg 1980;139:660-4.
25. Katz TS, Mendenhall WM, Morris CG, et al. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 2002;24:821-9.
26. Kingdom TT, Kaplan MJ. Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 1995;17:184-9.
27. Lee SP, Shimizu KT, Tran LM, et al. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope 1994;104:121-6.
28. Lohr F, Pirzkall A, Debus J, et al. Conformal three-dimensional photon radiotherapy for paranasal sinus tumors. Radiother Oncol 2000;56:227-31.
29. Loree TR, Mullins AP, Spellman J, et al. Head and neck mucosal melanoma: a 32-year review. Ear Nose Throat J 1999;78:372-5.
30. Lund VJ, Howard DJ, Harding L, et al. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999;109:208-11.
31. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer 1997;80:1373-86.
32. Matias C, Corde J, Soares J. Primary malignant melanoma of the nasal cavity: a clinicopathologic study of nine cases. J Surg Oncol 1988;39:29-32.
33. Mizoe JE, Tsujii H, Kamada T, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:358-64.
34. Monroe AT, Bhandare N, Morris CG, et al. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005;61:856-64.
35. Munter MW, Debus J, Hof H, et al. Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study. Strahlenther Onkol 2002;178:517-23.
36. Munter MW, Thilmann C, Hof H, et al. Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol 2003;66:313-21.
37. Nandapalan V, Roland NJ, Helliwell TR, et al. Mucosal melanoma of the head and neck. Clin Otolaryngol Allied Sci 1998;23:107-16.
38. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003;129:864-8.
39. Parsons JT, Mendenhall WM, Mancuso AA, et al. Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses. Int J Radiat Oncol Biol Phys 1988;14:11-22.
40. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002;24:247-57.
41. Pirzkall A, Carol M, Lohr F, et al. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys 2000;48:1371-80.
42. Pirzkall A, Debus J, Haering P, et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys 2003;55:362-72.
43. Prasad ML, Patel S, Hoshaw-Woodard S, et al. Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am J Surg Pathol 2002;26:883-92.
44. Purdy JA. Intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 1996;35:845-6.
45. Sakai S, Kubo T, Mori N, et al. A study of the late effects of radiotherapy and operation on patients with maxillary cancer. A survey more than 10 years after initial treatment. Cancer 1988;62:2114-7.
46. Salz H, Wiezorek T, Scheithauer M, et al. IMRT with compensators for head-and-neck cancers. Treatment technique, dosimetric accuracy, and practical experiences. Strahlenther Onkol 2005;181:665-72.
47. Schad LR, Gademann G, Knopp M, et al. Radiotherapy treatment planning of basal meningiomas: improved tumor localization by correlation of CT and MR imaging data. Radiother Oncol 1992;25:56-62.
48. Schafer M, Munter M, Sterzing F, et al. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT. Strahlenther Onkol 2005;181:587-94.
49. Schlegel W, Kneschaurek P. [Inverse radiotherapy planning.] Strahlenther Onkol 1999;175:197-207.
50. Schlegel W, Pastyr O, Bortfeld T, et al. Stereotactically guided fractionated radiotherapy: technical aspects. Radiother Oncol 1993;29:197-204.
51. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Carbon ion radiation therapy for chordomas and low grade chondrosarcomas - current status of the clinical trials at GSI. Radiother Oncol 2004;73:Suppl 2:S53-6.
52. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005;104:338-44.
53. Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients. Strahlenther Onkol 2003;179:598-605.
54. Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004;58:631-40.
55. Shah JP, Huvos AG, Strong EW. Mucosal melanomas of the head and neck. Am J Surg 1977;134:531-5.
56. Shibuya H, Takeda M, Matsumoto S, et al. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys 1993;25:35-9.
57. Shukovsky LJ, Fletcher GH. Retinal and optic nerve complications in a high dose irradiation technique of ethmoid sinus and nasal cavity. Radiology 1972;104:629-34.
58. Snow GB, van der Esch EP, van Slooten EA. Mucosal melanomas of the head and neck. Head Neck Surg 1978;1:24-30.
59. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
60. Stern SJ, Guillamondegui OM. Mucosal melanoma of the head and neck. Head Neck 1991;13:22-7.
61. Sterzing F, Munter MW, Schafer M, al. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlenther Onkol 2005;181:42-8.
62. Temam S, Mamelle G, Marandas P, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005;103:313-9.
63. Thilmann C, Zabel A, Grosser KH, et al. Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer 2001;96:341-9.
64. Trotti A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol 1993;9:246-50.
65. Wada H, Nemoto K, Ogawa Y, et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 2004;59:495-500.
66. Waldron JN, O'Sullivan B, Warde P, et al. Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy. Int J Radiat Oncol Biol Phys 1998;41:361-9.
67. Webb S. Advances in treatment with intensity-modulated conformal radiotherapy. Tumori 1998;84:112-26.